These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Competitive inhibitor binding assay (CIBA) of ACE inhibitors. Grönhagen-Riska C; Tikkanen I; Fyhrquist F Acta Med Scand Suppl; 1986; 714():43-7. PubMed ID: 3033999 [TBL] [Abstract][Full Text] [Related]
6. Inhibitor binding assay of rat serum angiotensin converting enzyme. Tikkanen I; Fyhrquist F; Forslund T Clin Sci (Lond); 1984 Aug; 67(2):237-41. PubMed ID: 6086211 [TBL] [Abstract][Full Text] [Related]
7. Effect of captopril and enalapril medication on the serum ACE test for sarcoidosis. Lieberman J; Zakria F Sarcoidosis; 1989 Sep; 6(2):118-23. PubMed ID: 2557660 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors: measurement of relative inhibitory potency and serum drug levels by radioinhibitor binding displacement assay. Jackson B; Cubela R; Johnston CI J Cardiovasc Pharmacol; 1987 Jun; 9(6):699-704. PubMed ID: 2442537 [TBL] [Abstract][Full Text] [Related]
9. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies. Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031 [TBL] [Abstract][Full Text] [Related]
10. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned? Erman A; Boner G; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825 [TBL] [Abstract][Full Text] [Related]
11. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ. Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113 [TBL] [Abstract][Full Text] [Related]
12. Enalapril treatment in a patient with impaired renal function and intolerance to captopril. Lindsjö M; Danielson BG; Weiss L; Wikström B Scand J Urol Nephrol Suppl; 1984; 79():99-101. PubMed ID: 6089326 [TBL] [Abstract][Full Text] [Related]
14. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs. McCaa RE; Gillespie JB Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226 [TBL] [Abstract][Full Text] [Related]
15. Effect of the time interval between blood sampling and assay on serum angiotensin I-converting enzyme activity from captopril-treated rats. Lai FM; Tanikella T; Herzlinger H; Cervoni P Eur J Pharmacol; 1980 Oct; 67(1):97-9. PubMed ID: 6252028 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats. Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254 [TBL] [Abstract][Full Text] [Related]
17. Measurement of angiotensin converting enzyme inhibitors in serum by radioinhibitor binding displacement assay. Jackson B; Cubela R; Johnston CI Biochem Pharmacol; 1987 Apr; 36(8):1357-60. PubMed ID: 3036166 [TBL] [Abstract][Full Text] [Related]
18. Two inhibitors of angiotensin-converting enzyme, enalapril and captopril, increase salt appetite of rats. Minsker DH; Bagdon WJ; Robertson RT; Bokelman DL J Toxicol Environ Health; 1984; 14(5-6):715-22. PubMed ID: 6097696 [TBL] [Abstract][Full Text] [Related]
19. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects. Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat. Bünning P Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]